Insiders · Profile

HIGH SUSANNA GATTI

Chief Operating Officer at Dyne Therapeutics. Filing since 23 Sep 2021. CIK 0001691005

Company
Date
Role
Action
Shares
Amount
Of holding
18 Sep 2024
Chief Operating Officer
Sold on a plan
8,976
$308.86K
6.4%
11 Sep 2024
Chief Operating Officer
Sold on a plan
5,270
$168.06K
3.6%
19 Aug 2024
Chief Operating Officer
Sold on a plan
2,910
$131.30K
2.0%
24 Jun 2024
Chief Operating Officer
Sold on a plan
10,163
$359.06K
6.4%
21 Jun 2024
Chief Operating Officer
Sold on a plan
29,787
$1.04M
16.7%
12 Jun 2024
Chief Operating Officer
Sold on a plan
40,000
$1.33M
21.2%
11 Jun 2024
Chief Operating Officer
Sold on a plan
5,270
$164.58K
3.4%
10 Jun 2024
Chief Operating Officer
Sold on a plan
80,000
$2.42M
34.2%
16 May 2024
Chief Operating Officer
Sold on a plan
2,738
$77.40K
1.7%
11 Mar 2024
Chief Operating Officer
Sold on a plan
2,292
$58.90K
1.4%
8 Mar 2024
Chief Operating Officer
Sold on a plan
27,199
$725.34K
14.6%
7 Mar 2024
Chief Operating Officer
Sold on a plan
1,591
$41.13K
0.8%
11 Dec 2023
Chief Operating Officer
Sold at will
1,616
$17.32K
0.9%
2 Nov 2023
Chief Operating Officer
Sold at will
9,939
$73.55K
9.5%
18 Sep 2023
Chief Operating Officer
Sold at will
2,672
$25.14K
2.5%
12 Sep 2023
Chief Operating Officer
Sold at will
1,635
$17.02K
1.5%
13 Jun 2023
Chief Operating Officer
Sold at will
1,625
$20.20K
1.5%
14 Mar 2023
Chief Operating Officer
Sold, plan not stated
1,559
$20.78K
1.4%
12 Dec 2022
Chief Operating Officer
Sold, plan not stated
751
$8.16K
0.7%
11 Mar 2022
Chief Operating Officer
Sold, plan not stated
765
$6.68K
1.0%
23 Sep 2021
Chief Operating Officer
Sold, plan not stated
2,451
$42.21K
6.8%
21 decisions on file.